Table 1 Surface marker expression of MSCs grown in the medium supplemented with large scale production of f-hPL
From: Human platelet lysate produced from leukoreduction filter contents enables sufficient MSC growth
Surface Marker | f-hPL #1 | f-hPL #2 | f-hPL #3 |
|---|---|---|---|
CD90 | 99.8% | 99.9% | 99.9% |
CD73 | 95.4% | 99.2% | 98.6% |
CD105 | 97.2% | 98.1% | 95.9% |
CD44 | 99.6% | 99.7% | 99.5% |
CD166 | 96.6% | 98.3% | 94.6% |
CD34 | 0.0% | 0.1% | 0.1% |
CD45 | 1.4% | 0.6% | 1.1% |
CD19 | 0.1% | 0.1% | 0.1% |
CD14 | 0.1% | 0.1% | 0.0% |
HLA-DR | 0.6% | 1.1% | 0.9% |